Full-Time

Consulting Project Team Lead

Investor

ClearView Healthcare Partners

ClearView Healthcare Partners

501-1,000 employees

Life sciences strategy consulting for biopharma

Compensation Overview

$190k - $220k/yr

+ Annual discretionary performance bonus

Boston, MA, USA + 2 more

More locations: San Francisco, CA, USA | New York, NY, USA

Hybrid

At least 40% of work time must be spent in the Boston, New York, or San Francisco office.

Bachelor's, Master's, MBA, PhD

Category
Consulting (1)
Required Skills
Forecasting
Data Analysis

Get referred to ClearView Healthcare Partners

See people who can refer or advise you

Requirements
  • A bachelor's degree with a science, engineering, or business major is required.
  • Five to seven years of experience in life sciences strategy consulting is required.
  • Experience leading projects involving buy-side and sell-side due diligence is required.
  • Experience with due diligence, technical and commercial expertise, tailored research approaches, forecasting, and strategic recommendations is required.
  • Experience working cross-functionally and bringing together various client teams is required.
  • A track record of managing simultaneous client projects and corresponding teams is required.
  • Strong problem-solving ability is required.
  • Strong written and oral communication skills are required.
  • Strong presentation skills and significant experience in client-facing situations are required.
  • Demonstrated leadership skills are required.
  • A highly analytical approach to solving complex problems is required.
  • Ability to work in the Boston, New York, or San Francisco office at least 40% of the time is required.
Responsibilities
  • Manage two to three projects of varying complexity simultaneously, depending on experience in the role.
  • Lead a broad range of Investor project types and bring order and structure to unfamiliar project situations or content areas.
  • Apply project management skills by raising issues early, designing effective internal and external agendas, and avoiding project fire drills.
  • Improve the quality, clarity, and simplicity of team output through early direction, hypothesis-based thinking, simplified storylines, impactful visuals, and concise writing.
  • Collaborate proactively with leadership, including early thought partnership and raising potential concerns about client experience, team experience, and team performance.
  • Provide mentorship and high-quality coaching within and outside project settings.
  • Drive high-impact client meetings independently by challenging client thinking, addressing difficult questions, and adding value beyond the team's work.
  • Develop and grow strong client relationships, resulting in account alignment and repeat client engagement.
  • Serve as a role model by helping others navigate challenges in client settings and within the firm.
  • Contribute to firm growth through internal initiatives and coaching or mentorship.
  • Uphold and model ClearView values.
Desired Qualifications
  • An advanced degree such as a master's in science, healthcare, or business administration, or a PhD, is preferred.
  • Enthusiasm for working collaboratively in a dynamic, team-based environment.
ClearView Healthcare Partners

ClearView Healthcare Partners

View

ClearView Healthcare Partners provides strategic consulting services exclusively for the life sciences sector, guiding pharmaceutical, biotechnology, medical devices, and diagnostics firms through decisions from discovery to commercialization. It completes project work with 100% of a dedicated team focused on a single client engagement, pairing rigorous scientific knowledge with business strategy, with many consultants holding life sciences PhDs. The firm differentiates itself through its strict one-client-per-project model, sector-only focus, and deep scientific expertise, plus international expansion to serve global clients. Its goal is to help life sciences companies grow, advance product development, and secure market access, creating value across the entire product lifecycle.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Newton, Massachusetts

Founded

2008

Get referred to ClearView Healthcare Partners

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • ClearView invested $4 million in Epistemic AI on January 10, 2025.
  • The March 2026 Salesforce-driven expert-network overhaul improves screening, scheduling, and compensation.
  • Seven open roles and 2026 hiring across Boston, London, San Francisco, and Gurgaon signal demand.

What critics are saying

  • Epistemic AI integration exposes ClearView to expensive technology bets if adoption stalls.
  • Expert-network Salesforce changes in March 2026 can disrupt delivery and consultant utilization.
  • AI tools commoditize strategy decks, squeezing premium advisory pricing by 2027.

What makes ClearView Healthcare Partners unique

  • 100% dedicated project teams keep ClearView focused on one client engagement at a time.
  • PhD-heavy consultants and founders from McKinsey, Leerink, and banking anchor scientific credibility.
  • London and Zurich offices, opened by 2026, deepen cross-border biopharma coverage.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Remote Work Options

Health Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Holidays

Flexible Work Hours

Wellness Program

Mental Health Support

Professional Development Budget

Conference Attendance Budget

Stock Options

Company Equity

Family Planning Benefits

Fertility Treatment Support

Home Office Stipend

Phone/Internet Stipend

Parental Leave

Adoption Assistance

Meal Benefits

Relocation Assistance

Employee Referral Bonus

Tuition Reimbursement

Professional Certification Support

Mentorship Program

Training Programs

Growth & Insights and Company News

Headcount

6 month growth

11%

1 year growth

11%

2 year growth

12%
PR Newswire
Mar 12th, 2025
The Addf'S Diagnostics Accelerator Authors New Paper On Ocular Biomarker Landscape, Highlighting Ocular Tests As A Tool For Early Detection Of Alzheimer'S Disease

New findings published in Alzheimer's Dementia suggest blood biomarkers are expected to become the standard method for diagnosing Alzheimer's, while ocular tests offer a non-invasive alternative for detecting at-risk patient populations NEW YORK, March 12, 2025 /PRNewswire/ -- The Alzheimer's Drug Discovery Foundation's (ADDF) Diagnostics Accelerator (DxA) authored a first-of-its-kind paper, "Unlocking ocular biomarkers for early detection of Alzheimer's disease," providing a landscape review of ocular biomarkers as another tool, alongside blood biomarkers, to aid in the early detection of Alzheimer's disease. The paper, which was published in Alzheimer's Dementia, shares an informed perspective on the role of ocular biomarkers in the broader Alzheimer's diagnostics space and what defines a true ocular biomarker, while also highlighting the potential for ocular screening to identify at-risk patients who would otherwise go undiagnosed. The authors' assessment is based on hours of in-depth interviews with leading neurologists, ophthalmologists, optometrists, and primary care physicians from across the United States

Citybiz
Jan 13th, 2025
ClearView Invests $4M in Epistemic AI

ClearView Healthcare Partners announced a $4 million minority investment in Epistemic AI to enhance its EpistemicGPT platform, which combines AI with a vast biomedical knowledge graph. This partnership aims to improve ClearView's service offerings by integrating AI technology, enhancing research and drug development processes. The collaboration underscores a commitment to advancing biomedical research and healthcare outcomes through innovative technology solutions.

Citybiz
Jan 13th, 2025
ClearView Healthcare Partners Invest In Epistemic AI

BOSTON, MA and WESTPORT, CT – 13 January 2025: ClearView Healthcare Partners, the leading life sciences strategic consultancy supporting Pharma... Read More

Digital Therapeutics Alliance
Nov 15th, 2023
DTx Commercialization Launch Playbook Case Study

Digital Therapeutics Alliance is thrilled to announce the release of its latest white paper in collaboration with Clearview Healthcare Partners!

Foundation Fighting Blindness
Feb 13th, 2023
The Foundation's long-term impact on moving the inherited retinal disease field forward towards treatments and cures. — Foundation Fighting Blindness

The Foundation Fighting Blindness partnered with ClearView Healthcare Partners to evaluate the impact of its funding and resources since 2005 on the clinical understanding and development of novel therapies for inherited retinal diseases (IRDs).